Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 8/18: (SEMI) (CIE) (RPTP) Higher; (EARS) (CERU) (PTLA) Lower

August 18, 2016 9:25 AM
Auris Medical Holding AG (Nasdaq: EARS) 64.1% LOWER; announced top-line results from the Phase 3 TACTT2 trial with Keyzilen (AM-101) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles